Cargando…
Target Selection of Directional Lead in Patients with Parkinson’s Disease
Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is sti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803701/ https://www.ncbi.nlm.nih.gov/pubmed/33162470 http://dx.doi.org/10.2176/nmc.tn.2020-0210 |
_version_ | 1783635999002198016 |
---|---|
author | SASAGAWA, Ayaka ENATSU, Rei KITAGAWA, Mayumi MIKAMI, Takeshi NAKAYAMA-KAMADA, Chie KURIBARA, Tomoyoshi HIRANO, Tsukasa ARIHARA, Masayasu MIKUNI, Nobuhiro |
author_facet | SASAGAWA, Ayaka ENATSU, Rei KITAGAWA, Mayumi MIKAMI, Takeshi NAKAYAMA-KAMADA, Chie KURIBARA, Tomoyoshi HIRANO, Tsukasa ARIHARA, Masayasu MIKUNI, Nobuhiro |
author_sort | SASAGAWA, Ayaka |
collection | PubMed |
description | Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is still unclear. Therefore, we investigated each structure’s effects and adverse effects using a directional lead implanted in the posterior STN adjacent to the cZI and Raprl in two patients with tremor-dominant PD. In Case 1, maximal reduction of tremor was obtained by stimulation toward the Vim, and stimulation toward the thalamic reticular nucleus (TRN) reduced verbal fluency, but did not induce dysarthria. In Case 2, maximal reduction of tremor was obtained by stimulation toward the dorsal STN and Raprl. Maximal reduction of rigidity was achieved by stimulation toward the dorsal STN, Raprl, and cZI. Bradykiensia was improved by stimulation in all directions, but dyskinesia and dysarthria were evoked by stimulation toward the dorsal STN and cZI. The directional lead may elucidate the stimulation effect of each structure and broaden target selection depending on patients’ symptoms and adverse effects. |
format | Online Article Text |
id | pubmed-7803701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japan Neurosurgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78037012021-01-14 Target Selection of Directional Lead in Patients with Parkinson’s Disease SASAGAWA, Ayaka ENATSU, Rei KITAGAWA, Mayumi MIKAMI, Takeshi NAKAYAMA-KAMADA, Chie KURIBARA, Tomoyoshi HIRANO, Tsukasa ARIHARA, Masayasu MIKUNI, Nobuhiro Neurol Med Chir (Tokyo) Technical Note Several structures including subthalamic nucleus (STN), the caudal zona incerta (cZI), the prelemniscal radiation (Raprl), and the thalamic ventral intermediate nucleus (Vim) have been reported to be useful for improving symptoms of Parkinson’s disease (PD). However, the effect of each target is still unclear. Therefore, we investigated each structure’s effects and adverse effects using a directional lead implanted in the posterior STN adjacent to the cZI and Raprl in two patients with tremor-dominant PD. In Case 1, maximal reduction of tremor was obtained by stimulation toward the Vim, and stimulation toward the thalamic reticular nucleus (TRN) reduced verbal fluency, but did not induce dysarthria. In Case 2, maximal reduction of tremor was obtained by stimulation toward the dorsal STN and Raprl. Maximal reduction of rigidity was achieved by stimulation toward the dorsal STN, Raprl, and cZI. Bradykiensia was improved by stimulation in all directions, but dyskinesia and dysarthria were evoked by stimulation toward the dorsal STN and cZI. The directional lead may elucidate the stimulation effect of each structure and broaden target selection depending on patients’ symptoms and adverse effects. The Japan Neurosurgical Society 2020-12 2020-11-06 /pmc/articles/PMC7803701/ /pubmed/33162470 http://dx.doi.org/10.2176/nmc.tn.2020-0210 Text en © 2020 The Japan Neurosurgical Society This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Technical Note SASAGAWA, Ayaka ENATSU, Rei KITAGAWA, Mayumi MIKAMI, Takeshi NAKAYAMA-KAMADA, Chie KURIBARA, Tomoyoshi HIRANO, Tsukasa ARIHARA, Masayasu MIKUNI, Nobuhiro Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title | Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title_full | Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title_fullStr | Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title_full_unstemmed | Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title_short | Target Selection of Directional Lead in Patients with Parkinson’s Disease |
title_sort | target selection of directional lead in patients with parkinson’s disease |
topic | Technical Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803701/ https://www.ncbi.nlm.nih.gov/pubmed/33162470 http://dx.doi.org/10.2176/nmc.tn.2020-0210 |
work_keys_str_mv | AT sasagawaayaka targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT enatsurei targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT kitagawamayumi targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT mikamitakeshi targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT nakayamakamadachie targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT kuribaratomoyoshi targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT hiranotsukasa targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT ariharamasayasu targetselectionofdirectionalleadinpatientswithparkinsonsdisease AT mikuninobuhiro targetselectionofdirectionalleadinpatientswithparkinsonsdisease |